Implantable dissolved oxygen sensor and methods of use
A sensor is provided for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site and in ex vivo applications. The sensor includes an article comprising a sensing medium retained within the implantable article by an oxygen-permeable material. The sensing medium comprises an MR contrast agent for oxygen. The sensor is configured to indicate the dissolved oxygen concentration of a fluid, e.g., in vivo at the tissue site, when subjected to an MR-based method.
1. A sensor for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site, comprising:
a solid implantable article having a sensing medium contained therein, the sensing medium comprising a magnetic resonance (MR) contrast agent for oxygen that has a spin-lattice relaxation time that is dependent on dissolved oxygen concentration;
wherein the solid implantable article is a solid oxygen-permeable polymeric siloxane matrix configured to prevent diffusion of the MR contrast agent from the implantable article while the sensor is implanted at the tissue site,
wherein the MR contrast agent is uniformly dispersed throughout the matrix and retained within the matrix, wherein the MR contrast agent comprises a siloxane or a perfluorocarbon, and wherein the MR contrast agent siloxane and the matrix siloxane are different types of siloxane, and
wherein the sensor is configured to indicate the dissolved oxygen concentration in vivo at the tissue site when subjected to an MR-based method.
2. The sensor of claim 1 , wherein the matrix comprises polydimethylsiloxane (PDMS).
3. The sensor of claim 1 , wherein the sensor is in the form of a bead.
4. The sensor of claim 1 , wherein the implantable article comprises a material that contrasts with the tissue site when subjected to MR-based spectroscopy.
5. The sensor of claim 1 , wherein the MR contrast agent is a siloxane.
6. The sensor of claim 5 , wherein the polymeric siloxane matrix is polydimethylsiloxane, and wherein the MR contrast agent comprises hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, hexamethylcyclotrisiloxane, octamethylcyclotetrasilane, decamethylgclopentasiloxane, dodecamethylcyclohexasiloxane, or a combination thereof.
7. The sensor of claim 1 , wherein the implantable article is 1 mm or more in size.
8. A sensor for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site, comprising:
a solid implantable article which comprises
a magnetic resonance (MR) contrast agent for oxygen that has a spin-lattice relaxation time that is dependent on dissolved oxygen concentration, the MR contrast agent comprising a siloxane or a perfluorocarbon; and
a solid oxygen-permeable polymeric siloxane matrix,
wherein the MR contrast agent is dispersed uniformly throughout and retained within the polymeric siloxane matrix, preventing diffusion of the MR contrast agent from the implantable article while the sensor is implanted at the tissue site, and
wherein the solid implantable article is 1 mm or more in size and configured to indicate the dissolved oxygen concentration in vivo at the tissue site when subjected to a MR-based method.
9. A sensor for measuring a dissolved oxygen concentration in vivo when implanted at a tissue site, comprising:
a solid implantable article having a sensing medium contained therein, the sensing medium comprising a magnetic resonance (MR) contrast agent for oxygen that has a spin-lattice relaxation time that is dependent on dissolved oxygen concentration;
wherein the implantable article is an oxygen-permeable polymeric siloxane matrix configured to prevent diffusion of the MR contrast agent from the implantable article while the sensor is implanted at the tissue site,
wherein the MR contrast agent is dispersed throughout the matrix and retained within the matrix, wherein the MR contrast agent comprises a siloxane or a perfluorocarbon, and wherein the MR contrast agent siloxane and the matrix siloxane are different types of siloxane, and
wherein the sensor is configured to (i) indicate the dissolved oxygen concentration in vivo at the tissue site when subjected to an MR-based methoda, and (ii) prevent diffusion of the MR contrast agent from the implantable article for a period of 1 to 6 months.